Usana Health Sciences, Inc. (USNA)
USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.87 per share a year ago.
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USNA or STVN: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now?
USNA vs. STVN: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now?
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is USANA Health Sciences (USNA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USNA or UCBJY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and UCB SA (UCBJY). But which of these two stocks presents investors with the better value opportunity right now?
Is USANA Health Sciences (USNA) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
USANA Health Sciences, Inc. (USNA) Q3 2024 Earnings Call Transcript
USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2024 Earnings Call Transcript October 23, 2024 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Douglas Hekking - CFO Brent Neidig - CCO Conference Call Participants Anthony Lebiedzinski - Fidelity Sidoti Linda Bolton Weiser - Davidson Operator Good day, and welcome to today's Usana Health Sciences Third Quarter Earnings Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode.
USANA Health Sciences (USNA) Q3 Earnings Surpass Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago.
USANA Health Sciences, Inc. (USNA) Q2 2024 Earnings Call Transcript
USANA Health Sciences, Inc. (NYSE:USNA ) Q2 2024 Earnings Conference Call July 24, 2024 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President & CEO Douglas Hekking - CFO Brent Neidig - Chief Commercial Officer Walter Noot - COO Conference Call Participants Anthony Lebiedzinski - Sidoti & Company Linda Bolton-Weiser - D.A. Davidson Doug Lane - Water Tower Research Operator Hello, and welcome to the USANA Health Sciences Second Quarter Earnings Call.
USANA Health Sciences (USNA) Misses Q2 Earnings and Revenue Estimates
USANA Health Sciences (USNA) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.89 per share a year ago.
